RICTOR activators encompass a diverse group of chemical compounds that enhance the activity of RICTOR by modulating various cellular signaling pathways. Insulin and IGF-1, for instance, both initiate signaling events through their respective receptors that result in the activation of the PI3K/AKT pathway, a critical route for RICTOR activation within the mTORC2 complex, essential for cellular survival and metabolic function. Similarly, AICAR and the naturally occurring compound resveratrol both activate AMPK, which leads to the inhibition of mTORC1 and subsequent relief of the inhibitory effect on RICTOR activity, emphasizing the interconnectivity of energy sensing and mTOR signaling. Metformin and ZMP, also activators of AMPK, follow this route to enhance RICTOR function, demonstrating a consistent theme of mTORC1 inhibition as a mechanism to augment RICTOR within mTORC2.
The chemical class termed 1700019N12Rik Activators refers to a set of compounds that are identified for their role in enhancing the activity of the gene labeled 1700019N12Rik within the murine genome. This particular gene, like others encoded in the genome, holds the blueprint for a specific protein or RNA molecule, and its activity is crucial for certain cellular processes. Activators within this chemical class engage with the gene or its transcription machinery to upregulate its expression. The discovery process for these activators typically begins with high-throughput screening, which allows researchers to assay thousands of chemicals for their ability to increase the expression of the 1700019N12Rik gene. This process often employs a reporter assay, where a detectable marker, such as a fluorescent or luminescent protein, is placed under the regulatory control of the 1700019N12Rik promoter. Compounds that trigger an upsurge in the reporter signal are then singled out for further investigation as potential activators of the gene.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin engages the insulin receptor, leading to the activation of the PI3K/AKT signaling pathway. RICTOR, as a critical component of the mTORC2 complex, is subsequently activated by AKT to facilitate cytoskeletal organization. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
AICAR activates AMPK, which can lead to the activation of TSC1/2 complex, subsequently inhibiting the mTORC1 complex. This releases RICTOR from feedback inhibition by mTORC1, enhancing its kinase activity in mTORC2. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol activates SIRT1, which can deacetylate and activate LKB1 leading to activation of AMPK. Activated AMPK positively regulates RICTOR-mTORC2 signaling by inhibiting TSC2 and mTORC1 pathway. | ||||||
Metformin | 657-24-9 | sc-507370 | 10 mg | $79.00 | 2 | |
Metformin is known to activate AMPK which can indirectly lead to the activation of RICTOR through the inhibition of mTORC1, as mTORC1-mediated feedback inhibition on mTORC2 is relieved. | ||||||
AICA-Riboside, 5′-Phosphate | 3031-94-5 | sc-202448B sc-202448C sc-202448 sc-202448A | 5 mg 10 mg 50 mg 100 mg | $184.00 $281.00 $505.00 $938.00 | 1 | |
ZMP is an analog of AMP and activates AMPK. This activation can enhance RICTOR function by inhibiting mTORC1 through the TSC1/2 complex, thereby promoting mTORC2 activity. | ||||||
Palmitoleic acid | 373-49-9 | sc-205424 sc-205424A sc-205424B sc-205424C sc-205424D | 100 mg 500 mg 1 g 5 g 10 g | $33.00 $135.00 $238.00 $1039.00 $1907.00 | 4 | |
Palmitoleic acid is a fatty acid that can activate peroxisome proliferator-activated receptors (PPARs). Activation of PPARs has been associated with the activation of AKT-mTORC2 signaling, which includes RICTOR activation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that, paradoxically, can lead to the activation of RICTOR. It reduces negative feedback loops that involve PI3K/AKT/mTORC1, potentially enhancing mTORC2 activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor that primarily targets mTORC1. Chronic treatment with rapamycin has been reported to upregulate mTORC2 activity, of which RICTOR is a key component. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin has been shown to activate AMPK, which in turn can inhibit mTORC1 signaling. This inhibition may indirectly enhance the activity of RICTOR within the mTORC2 pathway. | ||||||